AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

EMVISION MEDICAL DEVICES LTD

1.775

-0.025-1.39%

Volume:8.74K

Turnover:15.57K

Market Cap:164.97M

PE:-15.46

High:1.795

Open:1.790

Low:1.775

Close:1.800

52wk High:2.430

52wk Low:1.630

Shares:92.94M

Float Shares:56.04M

Volume Ratio:3.37

T/O Rate:0.02%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.115

EPS(LYR):-0.115

ROE:-70.55%

ROA:-27.95%

PB:17.77

PE(LYR):-15.47

Loading ...

Overview Company News Filings

EMVision Medical Devices Says Seven Hospitals Actively Enrolling Patients For Point-Of-Care Brain Scanner Validation Trial

MT Newswires Live

EMVision Medical Devices Starts Brain Scanner Device Study

MT Newswires Live

EMVision Medical Devices Names New CFO

MT Newswires Live

BRIEF-Emvision Medical Devices Appoints Karl Pechmann As CFO

EMvision Medical Devices - Appoints Karl Pechmann as CFO Starting Feb 2026

THOMSON REUTERS

EMvision Medical Devices Ltd-Appointment of Chief Financial Officer

THOMSON REUTERS

EMvision Medical Devices Ltd-Emvo - Distribution Schedule

THOMSON REUTERS

BRIEF-Emvision Medical Devices Says Oversubscribed SPP Raises A$2.0M

EMvision Medical Devices Ltd-Oversubscribed Spp Raises $2.0M

THOMSON REUTERS

EMVision Closes Oversubscribed AU$2 Million Share Purchase Plan Early

MT Newswires Live

3 ASX Penny Stocks With Over A$100M Market Cap

Simply Wall St.

EMVision Executes Grant Agreement With Commonwealth of Australia

MT Newswires Live

EMVision Medical Devices Equity Raise Less Dilutive Than Anticipated -- Market Talk

EMVision Starts Workflow Assessment, Data Collection Study of First Responder Brain Scanner for Stroke Patients

MT Newswires Live

EMVision Medical Devices Raises AU$12 Million via Share Placement; Shares Down 10%

MT Newswires Live

EMvision Medical Devices - to Raise a$12.0 Mln via Placement at Issue Price of a$1.94 per Share

THOMSON REUTERS

BRIEF-Emvision Medical Devices Seeks Trading Halt

EMVision Wins AU$3 Million Funding to Conduct Stroke Care Studies

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EMV.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EMV.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EMV.AU\",,,,,undefined,":{"symbol":"EMV.AU","market":"AU","secType":"STK","nameCN":"EMVISION MEDICAL DEVICES LTD","latestPrice":1.775,"timestamp":1770852265872,"preClose":1.8,"halted":0,"volume":8738,"delay":0,"changeRate":-0.013888888888888963,"nameEN":"EMVISION MEDICAL DEVICES LTD","floatShares":56036873,"shares":92938604,"eps":-0.114799,"marketStatus":"Trading","change":-0.025,"latestTime":"02-12 10:29:55 AEDT","open":1.79,"high":1.795,"low":1.775,"amount":15573,"amplitude":0.011111,"askPrice":1.795,"askSize":11244,"bidPrice":1.77,"bidSize":4709,"shortable":3,"etf":0,"ttmEps":-0.114799,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770872400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":1.8,"openAndCloseTimeList":[[1770850800000,1770872400000]],"volumeRatio":3.368088,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EMV.AU\",,,,,undefined,":{"symbol":"EMV.AU","floatShares":56036873,"roa":"-27.95%","roe":"-70.55%","lyrEps":-0.114761,"volumeRatio":3.368088,"shares":92938604,"dividePrice":0,"high":1.795,"amplitude":0.011111,"preClose":1.8,"low":1.775,"week52Low":1.63,"pbRate":"17.77","psRate":"32.66","week52High":2.43,"institutionHeld":0,"latestPrice":1.775,"committee":-0.409641,"eps":-0.114799,"divideRate":0,"volume":8738,"delay":0,"ttmEps":-0.114799,"open":1.79,"prevYearClose":1.78,"prevWeekClose":1.76,"prevMonthClose":1.77,"prevQuarterClose":1.78,"fiveDayClose":1.75,"twentyDayClose":1.8,"sixtyDayClose":1.87},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EMV.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EMV.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EMV.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606559277","title":"EMVision Medical Devices Says Seven Hospitals Actively Enrolling Patients For Point-Of-Care Brain Scanner Validation Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2606559277","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606559277?lang=en_us&edition=fundamental","pubTime":"2026-01-27 13:20","pubTimestamp":1769491233,"startTime":"0","endTime":"0","summary":"EMVision Medical Devices  said seven hospitals, including two trial locations in Australia and four in the US, are enrolling patients for the validation trial for the emu point-of-care brain scanner, according to a Tuesday Australian bourse filing.Several patients were recruited and scanned at each site as part of training verification. Feedback from users and the evaluation of training verification data led to the development of a software feature that will provide users with real-time feedback on scan quality at the point of acquisition. This feature is being tested in-house ahead of integration into emu devices.At the request of two participating trial sites, additional emu devices were shipped to support the activation of additional hospital network sites within the New York-based Mt Sinai and Houston-based Memorial Hermann healthcare systems.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","EMV.AU"],"gpt_icon":0},{"id":"2586421861","title":"EMVision Medical Devices Starts Brain Scanner Device Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2586421861","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586421861?lang=en_us&edition=fundamental","pubTime":"2025-11-27 11:10","pubTimestamp":1764213005,"startTime":"0","endTime":"0","summary":"EMVision Medical Devices  started an aeromedical feasibility and usability study of its first responder brain scanner device, according to a Thursday filing with the Australian bourse.The study, designed to determine if the device's aeromedical workflow is suitable for use in an emergency aeromedical stroke response, is expected to be completed in the first quarter of fiscal 2026, the filing said.The company's shares were down 1% in recent Thursday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","EMV.AU"],"gpt_icon":0},{"id":"2582386063","title":"EMVision Medical Devices Names New CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2582386063","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582386063?lang=en_us&edition=fundamental","pubTime":"2025-11-11 10:13","pubTimestamp":1762827183,"startTime":"0","endTime":"0","summary":"EMVision Medical Devices (ASX:EMV) named Karl Pechmann as its Chief Financial Officer, effective February 2026, according to a Tuesday Australian bourse filing.Its shares fell a little over 1% in recent trading on Tuesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XJO.AU","XAO.AU","XKO.AU","BK7007","EMV.AU"],"gpt_icon":0},{"id":"2582811063","title":"BRIEF-Emvision Medical Devices Appoints Karl Pechmann As CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2582811063","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582811063?lang=en_us&edition=fundamental","pubTime":"2025-11-11 08:03","pubTimestamp":1762819405,"startTime":"0","endTime":"0","summary":"BRIEF-Emvision Medical Devices Appoints Karl Pechmann As CFO Nov 11 (Reuters) - EMvision Medical Devices Ltd EMV.AX:APPOINTMENT OF CHIEF FINANCIAL OFFICERAPPOINTS KARL PECHMANN AS CFO STARTING FEB 2026Further company coverage: EMV.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nTUEC5RD7J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","EMV.AU"],"gpt_icon":0},{"id":"2582854473","title":"EMvision Medical Devices - Appoints Karl Pechmann as CFO Starting Feb 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2582854473","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582854473?lang=en_us&edition=fundamental","pubTime":"2025-11-11 06:17","pubTimestamp":1762813057,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nTUEC5RD7J:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EMV.AU","BK7007"],"gpt_icon":0},{"id":"2582385440","title":"EMvision Medical Devices Ltd-Appointment of Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2582385440","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582385440?lang=en_us&edition=fundamental","pubTime":"2025-11-11 06:17","pubTimestamp":1762813057,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nTUEC5RD7J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EMV.AU","BK7007"],"gpt_icon":0},{"id":"2580425508","title":"EMvision Medical Devices Ltd-Emvo - Distribution Schedule","url":"https://stock-news.laohu8.com/highlight/detail?id=2580425508","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580425508?lang=en_us&edition=fundamental","pubTime":"2025-11-03 09:54","pubTimestamp":1762134874,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nTUE5LX5VY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","EMV.AU"],"gpt_icon":0},{"id":"2579879483","title":"BRIEF-Emvision Medical Devices Says Oversubscribed SPP Raises A$2.0M","url":"https://stock-news.laohu8.com/highlight/detail?id=2579879483","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579879483?lang=en_us&edition=fundamental","pubTime":"2025-10-31 08:53","pubTimestamp":1761871980,"startTime":"0","endTime":"0","summary":"BRIEF-Emvision Medical Devices Says Oversubscribed SPP Raises A$2.0MOct 31 (Reuters) - EMvision Medical Devices Ltd EMV.AX:OVERSUBSCRIBED SPP RAISES $2.0MALL CURRENCIES IN AUDFurther company coverage: EMV.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nTUE66KCDT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","EMV.AU"],"gpt_icon":0},{"id":"2579102250","title":"EMvision Medical Devices Ltd-Oversubscribed Spp Raises $2.0M","url":"https://stock-news.laohu8.com/highlight/detail?id=2579102250","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579102250?lang=en_us&edition=fundamental","pubTime":"2025-10-31 07:42","pubTimestamp":1761867747,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nTUE66KCDT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EMV.AU","BK7007"],"gpt_icon":0},{"id":"2577845605","title":"EMVision Closes Oversubscribed AU$2 Million Share Purchase Plan Early","url":"https://stock-news.laohu8.com/highlight/detail?id=2577845605","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577845605?lang=en_us&edition=fundamental","pubTime":"2025-10-21 14:15","pubTimestamp":1761027350,"startTime":"0","endTime":"0","summary":"EMVision Medical Devices (ASX:EMV) closed its AU$2 million share purchase plan (SPP) ahead of schedule after strong investor demand pushed applications beyond the offer cap, according to a Tuesday Aus","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EMV.AU","BK7007"],"gpt_icon":0},{"id":"2577603895","title":"3 ASX Penny Stocks With Over A$100M Market Cap","url":"https://stock-news.laohu8.com/highlight/detail?id=2577603895","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577603895?lang=en_us&edition=fundamental","pubTime":"2025-10-21 03:02","pubTimestamp":1760986935,"startTime":"0","endTime":"0","summary":"The Australian market started the week strong, with the XJO climbing above 9,000 points, driven by gains in the financials sector as anticipation builds around a key meeting between Anthony Albanese and Donald Trump. In this context of economic shifts and strategic discussions on critical minerals, penny stocks remain an intriguing investment area for those seeking potential growth in smaller or newer companies. Despite their outdated name, these stocks can still offer surprising value when...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/3031000-choice2-main-header/1585186655644","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3031000-choice2-main-header/1585186655644"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/capital-goods/asx-gwa/gwa-group-shares/news/3-asx-penny-stocks-with-over-a100m-market-cap","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/capital-goods/asx-gwa/gwa-group-shares/news/3-asx-penny-stocks-with-over-a100m-market-cap","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GWA.AU","BK7088","BK7143","BK7061","BK7012","WAF.AU","IGL.AU","BKI.AU","EMV.AU","BK7058","DSK.AU","MTO.AU","BK7506","BK7045","PPL.AU","BK7007","BK7128","BK7104","BK7048","PPS.AU","CLX.AU","EZZ.AU","BK7503","BK7016","VRS.AU","BK7050","LBL.AU"],"gpt_icon":0},{"id":"2575269824","title":"EMVision Executes Grant Agreement With Commonwealth of Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2575269824","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575269824?lang=en_us&edition=fundamental","pubTime":"2025-10-14 15:20","pubTimestamp":1760426417,"startTime":"0","endTime":"0","summary":"EMVision Medical Devices  has executed the Cooperative Research Centres Projects grant agreement with the Commonwealth of Australia, according to a Tuesday filing with the Australian bourse.The company has received the first grant payment of AU$453,566, the filing said.Payment of grant instalments is conditional, and the Australian Government may terminate the agreement if the company does not comply with the obligation under it, the filing added.Shares of the company rose past 4% on market close.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","XJO.AU","XAO.AU","EMV.AU","XKO.AU"],"gpt_icon":0},{"id":"2571876870","title":"EMVision Medical Devices Equity Raise Less Dilutive Than Anticipated -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2571876870","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571876870?lang=en_us&edition=fundamental","pubTime":"2025-09-29 08:51","pubTimestamp":1759107060,"startTime":"0","endTime":"0","summary":"0051 GMT - EMVision Medical Devices bull Bell Potter raises its target on the stock after a A$12 million equity raising at A$1.94/share. Bell Potter analyst Martyn Jacobs had expected a raising of A$20 million in FY 2026 at A$1.50/share, \"so this raising is less dilutionary than expected,\" he says. The broker's target goes to A$3.15 from A$2.95. It reiterates a buy rating. EMVision is down 1.3% at A$1.915. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMV.AU","BK4215","EQR","BK7007","BK4588","BK4585"],"gpt_icon":0},{"id":"2569742927","title":"EMVision Starts Workflow Assessment, Data Collection Study of First Responder Brain Scanner for Stroke Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2569742927","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569742927?lang=en_us&edition=fundamental","pubTime":"2025-09-24 07:56","pubTimestamp":1758671769,"startTime":"0","endTime":"0","summary":"EMVision Medical Devices  launched a pre-hospital mobile stroke unit study, a two-stage workflow assessment and data collection study of the firm's first responder brain scanner, in the Melbourne Mobile Stroke Unit, according to a Wednesday Australian bourse filing.The first stage will evaluate the usability and workflow integration of the first responder brain scanner within the mobile stroke unit environment in the hyperacute stroke phase, the filing said. It will enroll 10 suspected stroke patients.The second stage will use the production-equivalent first responder device to collect scan data matched with ground-truth radiological imaging to support the advancement and evaluation of the firm's artificial intelligence-enhanced stroke detection algorithms, per the filing.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EMV.AU","BK7007"],"gpt_icon":0},{"id":"2568459543","title":"EMVision Medical Devices Raises AU$12 Million via Share Placement; Shares Down 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568459543","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568459543?lang=en_us&edition=fundamental","pubTime":"2025-09-17 11:36","pubTimestamp":1758080210,"startTime":"0","endTime":"0","summary":"EMVision Medical Devices  secured firm commitments to raise AU$12 million through the issue of 6.2 million new shares at AU$1.94 apiece, according to a Wednesday filing with the Australian bourse.The placement also involves free attaching options exercisable at AU$3.40 each and expiring two years from issue on a three-for-four basis.Additionally, the company will offer a share purchase plan to eligible shareholders to raise up to a further $1 million, accepting oversubscriptions capped at a total of $2 million, the filing said.Proceeds will be deployed over fiscal 2026 and 2027 for the US Food and Drug Administration submission and initial commercialization activities for the emu device and the First Responder program, according to the filing.Shares fell almost 10% in afternoon trade Wednesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EMV.AU","BK7007"],"gpt_icon":0},{"id":"2568434177","title":"EMvision Medical Devices - to Raise a$12.0 Mln via Placement at Issue Price of a$1.94 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2568434177","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568434177?lang=en_us&edition=fundamental","pubTime":"2025-09-17 07:28","pubTimestamp":1758065339,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250916:nFWN3V30TG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","EMV.AU"],"gpt_icon":0},{"id":"2567163274","title":"BRIEF-Emvision Medical Devices Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2567163274","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567163274?lang=en_us&edition=fundamental","pubTime":"2025-09-15 07:42","pubTimestamp":1757893331,"startTime":"0","endTime":"0","summary":"BRIEF-Emvision Medical Devices Seeks Trading Halt Sept 15 (Reuters) - EMvision Medical Devices Ltd EMV.AX:SEEKS TRADING HALT PENDING ANNOUNCEMENT ON CAPITAL RAISINGFurther company coverage: EMV.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250914:nFWN3UZ08B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","EMV.AU"],"gpt_icon":0},{"id":"2559998154","title":"EMVision Wins AU$3 Million Funding to Conduct Stroke Care Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2559998154","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559998154?lang=en_us&edition=fundamental","pubTime":"2025-08-15 08:14","pubTimestamp":1755216867,"startTime":"0","endTime":"0","summary":"EMVision Medical Devices  won AU$3 million in non-dilutive grant funding from the Australian government to study ways of improving stroke care through its emu brain scanners, according to a Friday filing with the Australian bourse.The data from the study will be used to drive the adoption and commercialisation of the brain scanner, the filing said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XKO.AU","XAO.AU","BK7007","XJO.AU","EMV.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}]}}